Searched for
ODYSSEY THERAPEUTICS
US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...- US stocks today: Space analytics firm HawkEye 360 valued at $3.15 billion after NYSE debutHawkEye 360's stock surged 30% on its Thursday debut, reaching a $3.15 billion valuation after raising $416 million in its U.S. IPO. The de...
- Rearranging booksRearranging also means revisiting stories, ideas, and memories. Forgotten gems resurface as you sift through the entire pile, triggering no...
- Load More